Comparative doses and costs of antipsychotic medication

Area of Science:

• Psychopharmacology
• Clinical Psychiatry
• Health Economics

Background:

• Establishing equivalent neuroleptic doses is crucial for clinical practice and comparative studies.
• Chlorpromazine serves as a standard reference for antipsychotic potency.

Purpose of the Study:

• To derive an empirically based table of equivalent neuroleptic doses.
• To compare this empirical table with expert-derived estimations.
• To calculate and compare the costs of different neuroleptics based on equivalent antipsychotic activity.

Main Methods:

• Systematic review of double-blind, controlled studies utilizing flexible neuroleptic dosage regimens in schizophrenia.
• Conversion of various neuroleptic doses to chlorpromazine equivalents (mg).
• Calculation of medication costs based on derived equivalent doses.

Main Results:

• An empirically derived table of neuroleptic dosage comparability was established.
• Comparison with expert opinion tables showed potential discrepancies.
• Cost analysis indicated that while absolute cost differences are minor, significant savings are achieved by prescribing the largest available dosage forms.

Conclusions:

• The empirically derived table offers a valuable tool for standardizing neuroleptic dosing in schizophrenia.
• Prescribing the highest possible dosage strength can lead to substantial cost reductions.
• Further research may explore the clinical implications of these cost-saving strategies.